Sheba Medical Center and Tel Aviv Sourasky Medical Center-Ichilov have joined AccuLine’s international clinical trial testing an Israeli-developed AI system designed to detect coronary artery disease noninvasively in just four minutes | Read More in ynet – Culture
Israeli hospitals join international clinical trial for AI heart attack risk assessment






